BioWorld

March 28, 2007

View Archived Issues

Aerovance Tops Off Series C By Garnering $32M Payout

After raising $28 million almost a year ago in the first tranche of a Series C financing, Aerovance Inc. brought in an additional $32 million in a second tranche, completing the $60 million round. (BioWorld Today) Read More

Frost Leads Three-Way Merger That Includes Acuity, Froptix

Read More

Regeneron Rises On Interim VEGF Trap-Eye Data In AMD

Read More

BioCryst Eyeing New Direction For Fodosine Following Setback

Read More

Regado Ends $23 Million Round;Now Developing Anticoagulant

Read More

MediciNova MS Phase II: Missed Endpoint, But Hope Remaining

Read More

Other News To Note

Read More

Clinic Roundup

Read More